NEW YORK, August 31, 2017 /PRNewswire/ --
If you want a Stock Review on PBH, SNN, NXTM, or AMDA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has issued research reports on Prestige Brands Holdings Inc. (NYSE: PBH), Smith & Nephew PLC (NYSE: SNN), Nxstage Medical Inc. (NASDAQ: NXTM), and Amedica Corp. (NASDAQ: AMDA). Medical equipment devices are designed to aid diagnosis, monitoring or treatment of medical conditions. The Medical Equipment market comprises surgical and medical instruments, surgical appliances and supplies, ophthalmic goods, dental laboratories, and in vitro reagents. Daily Stock Tracker published free research reports on these stocks today at:
Prestige Brands Holdings
Tarrytown, New York headquartered Prestige Brands Holdings Inc.'s shares gained 0.28%, closing Wednesday's trading session at $51.00. The stock recorded a trading volume of 223,680 shares. The Company's shares are trading 1.66% below their 50-day moving average. Additionally, shares of the Company, which through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally, have a Relative Strength Index (RSI) of 44.76.
On August 03rd, 2017, Prestige Brands reported financial results for the first fiscal quarter ended June 30th, 2017. In Q1 FY18, revenues were $256.6 million; gross profit margin was 55.9%; advertising and promotion expense was $36.9 million; and net income totaled $33.8 million. The Company's net debt position was approximately $2.1 billion as of June 30th, 2017. See our free and comprehensive research report on PBH at:
Smith & Nephew
On Wednesday, shares in London, the UK headquartered Smith & Nephew PLC recorded a trading volume of 367,423 shares. The stock rose 0.36%, ending the day at $35.93. The Company's shares have advanced 1.99% in the past month, 1.10% in the previous three months, and 19.45% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.35% and 11.40%, respectively. Furthermore, shares of Smith & Nephew, which designs, develops, and sells medical devices worldwide, have an RSI of 59.44. SNN free research report is just a click away at:
Lawrence, Massachusetts headquartered Nxstage Medical Inc.'s stock finished the day 0.83% lower at $27.53 with a total trading volume of 1.29 million shares. The Company's shares have advanced 18.15% in the last one month, 25.14% in the previous three months, and 5.04% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 7.05% and 5.71%, respectively. Additionally, shares of Nxstage Medical, which develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure, have an RSI of 50.69.
On August 22nd, 2017, research firm Leerink Partners downgraded the Company's stock rating from 'Outperform' to 'Market Perform'.
On August 24th, 2017, Nxstage Medical announced that the NxStage® System One™ is now used in nine of the top ten nephrology hospitals in the US, and fifteen of the top twenty, as identified by US News & World Report. The System One simplifies care in acute care settings and allows staff to deliver the prescribed renal replacement therapy via a variety of modalities to critically ill patients. Sign up for your complimentary report on NXTM at:
Shares in Salt Lake City, Utah headquartered Amedica Corp. ended yesterday's session 1.56% higher at $0.32. The stock recorded a trading volume of 171,358 shares. The Company's shares have advanced 13.16% over the previous three months. The stock is trading 11.77% below its 50-day moving average. Moreover, shares of Amedica, which develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the US, Europe, and South America, have an RSI of 38.01.
On August 14th, 2017, Amedica announced that the special meeting of stockholders scheduled for that day has been adjourned, and will reconvene at 9:00 a.m. local time on September 07th, 2017, at the Company's offices located at 1885 West 2100 South, Salt Lake City, Utah 84119. The record date for stockholders entitled to vote at the special meeting remains July 19th, 2017. Register for free on DailyStockTracker.com and download the latest research report on AMDA at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.